A COMPARISON OF 3-FACTOR PROTHROMBIN COMPLEX CONCENTRATE PRODUCTS IN WARFARIN-ASSOCIATED ICH

被引：0
|
作者：
Tucker, Natalie [1 ]
Cook, Ryan [2 ]
Cave, Brandon [1 ]
Jones, Morgan [1 ]
机构：
[1] Methodist Univ Hosp, Memphis, TN USA
[2] Methodist Healthcare, Memphis, TN USA
来源：
CRITICAL CARE MEDICINE | 2020年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
979
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PROTHROMBIN COMPLEX CONCENTRATE USE IN WARFARIN-ASSOCIATED INTRACEREBRAL HEMORRHAGE IS NOT ASSOCIATED WITH HIGHER THROMBOEMBOLIC RISKS
    Chou, Sherry
    Konigsberg, Rachael
    Cai, Xuemei
    Bresette, Linda
    Henderson, Galen
    Sorond, Farzaneh
    Ropper, Allan
    Feske, Steven
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A421 - A421
  • [22] 3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
    Hays, William Blake
    Billups, Kelsey
    Nicholson, Jessica
    Bailey, Abby M.
    Gregory, Haili
    Weeda, Erin R.
    Weant, Kyle A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2025, 58 (02) : 276 - 283
  • [23] Comparative Thromboembolic Risk of 3-Factor Versus 4-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal
    Wagner, S.
    Kaide, C.
    Li, J.
    Reichert, E.
    ANNALS OF EMERGENCY MEDICINE, 2019, 74 (04) : S120 - S120
  • [24] Comparison of 3-factor versus 4-factor prothrombin complex concentrate for emergent warfarin reversal: a systematic review and meta-analysis
    David J. Margraf
    Sarah J. Brown
    Heather L. Blue
    Tamara L. Bezdicek
    Julian Wolfson
    Scott A. Chapman
    BMC Emergency Medicine, 22
  • [25] Systematic review: 3-factor versus 4-factor prothrombin complex concentrate for warfarin reversal: Does it matter?
    Voils, Stacy A.
    Baird, Brian
    THROMBOSIS RESEARCH, 2012, 130 (06) : 833 - 840
  • [26] Comparison of 3-factor versus 4-factor prothrombin complex concentrate for emergent warfarin reversal: a systematic review and meta-analysis
    Margraf, David J.
    Brown, Sarah J.
    Blue, Heather L.
    Bezdicek, Tamara L.
    Wolfson, Julian
    Chapman, Scott A.
    BMC EMERGENCY MEDICINE, 2022, 22 (01)
  • [27] Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage
    Daniel Fischer
    Jeffrey Sorensen
    Gabriel V. Fontaine
    Neurocritical Care, 2018, 28 : 43 - 50
  • [28] Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage
    Fischer, Daniel
    Sorensen, Jeffrey
    Fontaine, Gabriel V.
    NEUROCRITICAL CARE, 2018, 28 (01) : 43 - 50
  • [29] RISK OF VENOUS THROMBOEMBOLISM AFTER RECEIVING PROTHROMBIN COMPLEX CONCENTRATE FOR WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE
    Felton, Diana
    Foley, Elizabeth M.
    Traub, Stephen J.
    Vodonos, Alina
    Ganetsky, Michael
    JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (01): : 1 - 6
  • [30] Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage
    Cicci, Corey D.
    Weiss, Ashley
    Dang, Cathyyen
    Stanton, Matthew
    Feldman, Ryan
    PHARMACOTHERAPY, 2022, 42 (05): : 366 - 374
12345